I think the best part of watching a rocket launch is not the countdown or roar, but the few seconds of silence when everyone waits to see whether it worked.

Looking at Rocket Lab (RKLB) today, I think the market has spent months sitting in that silence.

On Nov. 18, during the “Mad Money” Lightning Round, a caller said Peter Beck is a great CEO, and Neutron is a huge driver of the stock.

I’m drawn to the rocket business, which means I like SpaceX. But you know what, I would take this. Rocket Lab has gotten too cheap.

Then came the warning: “I think you have a good one. It’s a spec!”

For context, RKLB closed at $50.99 on Oct. 20, according to Yahoo Finance. At that point, it was down 26.91% year to date and about 59% over six months, though still up 16.90% over one year and 1,111.16% over three. 

Repeated delays to its Neutron rocket, heavy share dilution to fund a major acquisition, widening near-term losses, and valuation resets have driven that recent drop, even as its core revenue and order backlog have grown.

Also Read: Jim Cramer says it’s a ‘great opportunity to sell’ RKLB stock

A Rocket Lab milestone that arrived just before the call

Cramer’s comment came days after Rocket Lab hit 100 electron launches, on a Nov. 14 mission for Japanese customer iQPS.

SpaceNews reported that it reached that mark faster than any other commercial rocket. The Motley Fool reported 96 successes in 100 launches and 21 launches so far in 2026, matching all of 2025.

“The next 100 Electrons are already booked, so we’re only accelerating from here,” Beck said in the company’s announcement.

More Jim Cramer:

I covered this stock in October when Cramer called Neutron’s delay “a great opportunity to sell.” The stock was at $53 then, traded to a low of $43 in early November before recovering to the 50s.

His tone has now flipped. That is not unusual because I have seen another call from him on RKLB. 

On April 27, Cramer called Rocket Lab “a winner,” and we saw it rally from a close of $82 that day to  $151 exactly a month after. 

Rocket Lab’s record quarter behind the “cheap” argument

Rocket Lab’s Q3 results, released Nov. 9, show why Cramer sees a gap between the business and the price. Revenue hit a record $268 million, up 73%. Backlog reached about $3.6 billion, up 52% from the end of Q2. 

The company signed more than $515 million in new Neutron launch contracts and generated positive GAAP operating cash flow of $7.2 million. Q4 revenue is guided to $270 million to $290 million.

Related: Jim Cramer says tumbling space stock is ‘done going down’

On the earnings call, management said Neutron’s first 16 launches are booked, with several sold at $70 million each. CFO Adam Spice said in the earnings call that Rocket Lab “could actually have booked more launches in Q3 for Neutron than we did, but we chose to go for higher ASP and lower volumes.”

It is choosing price over volume because it has pricing power. It is also a company selling a rocket that has not yet flown.

Why is Rocket Lab still “a spec?”

The net loss widened to about $79.7 million from $18.3 million a year earlier. That includes a $27.3 million loss on debt extinguishment and $21.3 million in transaction costs tied to the pending Iridium Communications acquisition, which still needs regulatory approval. I covered that deal’s dilution earlier.

Neutron’s first launch is now targeted for no earlier than 2027 after engineers found voids in the Stage 1 tank’s forward dome. But Spice mentioned in the earnings call that “nothing is really going to permanently reverse the cash flow negativity until Neutron is really into production.”

Valuation is the other half of the debate. Yahoo Finance shows the stock at about 38 times sales, compared to 3.2 times for the aerospace and defense sector and about 8.4 times for peers, and its model flags the shares as overvalued. 

So “too cheap” compared with its own history can still mean expensive against everyone else. Both can be true.

Rocket Lab completed its 100th Electron launch on a Nov. 14 mission for Japanese customer iQPS.

MARTY MELVILLE / Getty Images

What to watch next from Rocket Lab

If tempted by Cramer’s call, these are the markers:

  • Results from Neutron’s Stage 1 tank testing
  • Regulatory approval of the Iridium deal
  • Q4 revenue against the $270 million to $290 million range
  • Whether Electron keeps its launch pace

Cramer’s own word was “spec,” which means size it so a bad outcome does not hurt. My read is that the business is clearly improving, and the stock has fallen far enough that his case is reasonable.

But a rocket that has not flown, a widening loss, and a 38x sales multiple leave little room for another delay. I think the best will arrive when Neutron actually flies.

More Stocks News